Aumovio Se · XETR:AMV0
Aumovio — H1 2026 Earnings Presentation
45 slides from Aumovio's earnings presentation, Aug 6, 2026
Slide 1: H1 2026 Results
H1 2026 Results Philipp von Hirschheydt – CEO Dr. Jutta A. Dönges – CFO Lutz Ackermann – Head of IR Ticker: AMV0 ISIN: DE000AUM0V10 Website: http://www.ir.aumovio.com IR Contact: ir@aumovio.com 6 August 2026 Investor Relations
Slide 2: Agenda
Agenda 1 Q2 Highlights 2 Financial Performance and Outlook 3 Capital Allocation Framework 4 Appendix Investor Relations @AUMOVIO SE
Slide 3: AUMOVIO and BMW expand electronics and brake partnership
AUMOVIO and BMW expand electronics and brake partnership Past warranty case settled amicably Expanded technology partnership and settlement agreement Impact on financials − AUMOVIO and BMW agreed to deepen long-term cooperation and Settlement: €350 mn strengthen technology partnership − The partners
Slide 4: Solid Q2 results in a challenging environment
Solid Q2 results in a challenging environment Adj. EBIT margin performance reflects execution discipline €4.307 mn €152 mn / 3.5% €-34 mn / €-174 mn Adj. Sales (excl. BMW) Adj. EBIT / Adj. EBIT margin (excl. BMW) Normalized FCF / adj. FCF (Incl. BMW €4.244 mn) (Incl. BMW €50 mn / 1.2%) − Moderate ad
Slide 5: Driving future growth through leading technologies
Driving future growth through leading technologies Strategic order intakes and technology progress in key areas Autonomous and Commercial Architecture and Network Safety and Motion (SAM) User Experience (UX) Mobility (ACM) Solutions (ANS) Autonomous Connected Safe Exciting Pioneering the autonomous
Slide 6: Building the foundation for scalable autonomous trucking
Building the foundation for scalable autonomous trucking From successful pilots to series deployment at scale General Aurora update: Customer adoption, driverless route expansion and fleet-scale targets reinforce AUMOVIO’s industrialization opportunity for AD safety-critical hardware and lifecycle s
Slide 7: Targeted R&D net / sales below 9% on track
Targeted R&D net / sales below 9% on track Driven by savings of >€200mn in 2026 and >€150mn in 2027 R&D cost reduction measures Annual savings R&D net / sales ratio impact Following a holistic approach …and consequent deployment …that help us delivering on our with diverse measures… leads to signifi
Slide 8: Agenda
Agenda 1 Q2 Highlights 2 Financial Performance and Outlook 3 Capital Allocation Framework 4 Appendix Investor Relations @AUMOVIO SE
Slide 9: Topline decline offset by disciplined transformation execution
Topline decline offset by disciplined transformation execution Q2 Adj. EBIT margin stable while normalized FCF slightly lower Adj. Sales (€ mn) Adj. EBIT (€ mn) Normalized FCF (€ mn) 3.5% 1.2% 3.5% -10.0% -8.6% -69.9% -9.2% -25 -34 -119 -140 4,714 4,244 4,307 167 152 Adj. FCF -144 50 Adj. FCF -174 Q
Slide 10: Profitability and FCF improvement in H1 despite sales headwinds
Profitability and FCF improvement in H1 despite sales headwinds H1 Free Cash Flow performance reflecting lower capex level Adj. Sales (€ mn) Adj. EBIT (€ mn) Normalized FCF (€ mn) 2.7% 1.8% 3.0% +34.1% -8.9% -8.2% -39.8% -0.8% 84 113 -261 -290 9,493 8,649 8,711 260 157 258 Adj. FCF -177 Adj. FCF -17
Slide 11: Sales performance impacted by challenging market environment
Sales performance impacted by challenging market environment Dominated by pricing and volume pressure (€ mn) Divestments Active Portfolio Management / Footprint Reduction Regional -52 -196 Sales exposure -586 -50 -2 100% -130 -66 16% -434 12% -152 21% 9,545 9,493 9,297 8,711 8,649 51% Sales Cairo Ot
Slide 12: R&D measures showing first results in profitability
R&D measures showing first results in profitability Adj. EBIT margin gradually improving YoY (Q2 25: 11.9%) (Q2 26: 11.4%) (€ mn) +0.6%p -0.1%p 2 19.5% 20.1% 3 12.0% 11.9% H1 2025 H1 2026 H1 2025 H1 2026 2.7% 3.0% 1 -64 43 -96 115 c. -100 1.8% 259 260 258 157 Adj. EBIT Deconsolidation Adj. EBIT Adj.
Slide 13: Adj. EBIT stable YoY supported by ANS
Adj. EBIT stable YoY supported by ANS SAM continues to focus on the transformation path (€ mn) ACM Adj. EBIT H1 2025 260 − Adj. Sales -12.6%, mainly due to FX effects H1 2025 H1 2026 as well as lower volumes − Adj. EBIT decline primarily driven by lower -0.1% -1.0% volumes and unfavorable product mi
Slide 14: H1 Normalized FCF slightly higher benefitting from lower capex
H1 Normalized FCF slightly higher benefitting from lower capex Adj. FCF impacted by restructuring & separation cash effects (€ mn) 605 Cash-effective costs include: -25 €233 mn restructuring -125 €55 mn spin-off & separation 448 -193 455 -148 157 113 -290 -177 Adj. EBIT / Adj. D&A Net Employee Benef
Slide 15: Net-cash position in H1 2026 remains strong
Net-cash position in H1 2026 remains strong Lower net pension liabilities due to lower discount rate (€ mn) Net Pension Liabilities (€ mn) -166 -6 30 1,389 -1 4.3%2 4.4%2 1,246 1,065 1,000 Net Cash FCF1 Other changes in Gross Financial Changes Derivative Net Cash As at Dec 31, 2025 As at Jun 30, 202
Slide 16: Operating in a changing and challenging market environment
Operating in a changing and challenging market environment Updated outlook for FY 2026 Actuals 2025 March 2026 August 2026 Lower light vehicle production expectations; active - portfolio management; delayed project ramp-ups; FX as Adj. Sales (€ bn) 18.5 17.0-18.5 17.0-17.5 of Dec 31, 2025; BMW settl
Slide 17: Updated outlook for ACM, SAM and UX
Operating in a changing and challenging market environment Updated outlook for ACM, SAM and UX Business Area Adj. Sales (€)1 Outlook Adj. EBIT margin (%)1 August 2026 − Significant (previously moderate) lower adj. Sales due Autonomous and to updated market assumptions, FX and lower volumes in ADAS a
Slide 18: Agenda
Agenda 1 Q2 Highlights 2 Financial Performance and Outlook 3 Capital Allocation Framework 4 Appendix Investor Relations @AUMOVIO SE
Slide 19: Capital allocation framework: Why and what
Capital allocation framework Why and what − As communicated in our CMD last year, AUMOVIO’s key focus was to drive the development of the business and execute on the required transformation ➢ Indication of a mid-term target dividend payout ratio of 10-30% of net income at the CMD − While our focus o
Slide 20: Capital allocation framework
Capital allocation framework Balancing financial flexibility, growth and shareholder returns Maintain Strong Balance Sheet and Financial Flexibility 1 − Build an investment grade credit profile − Ensure sufficient liquidity through the cycle Invest in Organic Growth 2 − Invest in value generating gr
Slide 21: Q&A Thank you!
Q&A Thank you!
Slide 22: Agenda
Agenda 1 Q2 Highlights 2 Financial Performance and Outlook 3 Capital Allocation Framework 4 Appendix Investor Relations @AUMOVIO SE
Slide 23: Business Areas ACM and ANS
Business Areas ACM and ANS Q2 development adj. Sales and adj. EBIT Autonomous and Commercial Mobility (ACM) Architecture and Network Solutions (ANS) Adj. Sales (€ mn) Adj. EBIT (€ mn) Adj. EBIT margin (%) Adj. Sales (€ mn) Adj. EBIT (€ mn) Adj. EBIT margin (%) +7 1 +26.1% -12.1% 5 -0.3% -7.4% 0.7% -
Slide 24: Business Areas SAM and UX
Business Areas SAM and UX Q2 development adj. Sales and adj. EBIT Safety and Motion (SAM) User Experience (UX) Adj. Sales (€ mn) Adj. EBIT (€ mn) Adj. EBIT margin (%) Adj. Sales (€ mn) Adj. EBIT (€ mn) Adj. EBIT margin (%) -9.6% -6.2% -81.5% -10.7% -8.5% 4.2% 4.2% -2.0% 5.4% 1,831 1,656 1,718 42 78
Slide 25: Key figures by Business Area (1/2)
Key figures by Business Area (1/2) Sales (€ mn) and EBIT (€ mn and as % of Sales) AUMOVIO Q1 25 Q2 25 Q3 25 Q4 25 FY 25 Q1 26 Q2 26 Sales 4,805 4,740 4,509 4,496 18,550 4,404 4,244 Sales growth (YoY) -1.8% -5.4% -6.8% -8.4% -5.6% -8.3% -10.0% EBIT -147 4 11 63 -70 -79 -390 EBIT margin -3.1% 0.1% 0.2
Slide 26: Key figures by Business Area (2/2)
Key figures by Business Area (2/2) Adj. Sales (€ mn) and adj. EBIT (€ mn and as % of adj. Sales) AUMOVIO Q1 251 Q2 251 Q3 251 Q4 251 FY 251 Q1 262 Q2 262 Adj. Sales 4,780 4,714 4,492 4,496 18,480 4,404 4,244 Adj. Sales growth (YoY) -7.8% -10.0% Adj. EBIT 93 167 153 308 721 106 50 Adj. EBIT margin 1.
Slide 27: Major project wins in Japan across all Business Areas
Major project wins in Japan across all Business Areas Delayed sourcing decisions, while order pipeline remains strong Q2 2026 Order Intake (€ mn) Highlights Order Intake Q2 2026 Regional split (%) − Increased share of RoW, due to major project 5,6951 wins in Japan across all BAs and various OEMs (0.
Slide 28: Focused project selection affecting regional growth outcomes
Focused project selection affecting regional growth outcomes Sales exposure and performance per region in Q2 2026 Sales exposure AUMOVIO Sales organic growth vs. vehicle production (YoY in %) Worldwide1 Europe Rest of World -0.2 3.9 17% -1.6 -1.5 12% -8.8 -10.5 51% North America China -0.2 20% -3.2
Slide 29: Financial development
Financial development Adj. Sales and adj. EBIT margin 2025 2026 Guidance of: − €18.5 bn adj. Sales − €17.0-17.5 bn adj. Sales − 3.9% adj. EBIT margin − 3.0-4.0% adj. EBIT margin 4,8 4,7 4,5 4,5 4,4 1 4,2 6,9% 3,5% 3,4% 1,9% 2,4% 1,2% Q1 2025 Q2 Q3 Q4 Q1 2026 Q2 Adj. Sales (€ bn) Adj. EBIT margin (%)
Slide 30: Transformation and one-off items impact EBIT and net income
Transformation and one-off items impact EBIT and net income Bridge from adj. EBIT to net income IFRS PnL item (€ mn) H1 2025 H1 2026 Key comments (H1 26 YoY) Adj. EBIT 260 157 Adj. EBIT decrease by 39.8% Key items − €210 mn restructuring and termination (PY €260 mn) Adjustments (incl. − €5 mn spin-o
Slide 31: H1 2026 Reconciliation adj. EBIT and Normalized FCF
H1 2026 Reconciliation adj. EBIT and Normalized FCF Figures in € mn EBIT reported -469 Reported Free Cash Flow -166 Amortisation of intangible PPA 18 Interest bearing investments 7 Cash in- and outflows for acquisition and selling of business Impairments 91 operations 4 Restructuring and termination
Slide 32: Disciplined Capex approach and efficient WC management
Disciplined Capex approach and efficient WC management Improving capital efficiency Capex (€ mn and as % of sales) Working Capital (€ mn) 2,588 2,462 2,440 2,138 2,223 2,224 278 Inventories 2,648 2,435 2,413 192 2,309 2,322 2,317 154 145 Trade accounts 134 97 receivable 3,713 3,493 3,443 3,153 3,315
Slide 33: Building a streamlined and highly competitive global footprint
Building a streamlined and highly competitive global footprint Ramp down aligned with ambition of <45 production locations 2025 2026 2027 2028 CLOSURE: CLOSURE: CLOSURE: CLOSURE: − Karben − Changsha − Gifhorn − Lianyungang (Production loc. closed Q4 25/ (Operational Exit1 Q1 26) (Operational Exit1 Q
Slide 34: Net periodic costs slightly higher than net periodic payments
Net periodic costs slightly higher than net periodic payments FY 2025 pension reconciliation (€ mn) Non-cash employees earning future pension Cash to pensioners payments -106 46 -29 0 3.5%1 68 -77 -20 29 Net periodic pension costs: 114 Net periodic payments: -97 -307 4.3% 1,355 1,065 31.12.2024 Serv
Slide 35: Germany accounts for majority of pension plans
Germany accounts for majority of pension plans FY 2025 Funded Status of Defined Benefit Obligation Reconciliation of Accrued Pension Liabilities per Region (€ mn) (€ mn) Germany Outside Germany 1,665 -1,224 2,730 2,286 34 1,031 1,065 1,062 444 -442 1 3 Partly Unfunded Accrued Pension Plan Assets inc
Slide 36: Interim 2026 IFRS Profit and Loss Statement
Interim 2026 IFRS Consolidated Financial Statement Profit and Loss Statement € millions H1 Q2 2026 2025 2026 2025 Sales 8,649 9,545 4,244 4,740 Cost of sales –7,091 –7,804 –3,528 –3,852 Gross profit on sales 1,558 1,741 716 888 Research and development expenses –1,600 –1,713 –768 –785 Selling and lo
Slide 37: Balance Sheet - Assets
Interim 2026 IFRS Consolidated Financial Statements Balance Sheet - Assets € millions 30.06.2026 31.12.2025 Goodwill 2,094 2,089 Other intangible assets 218 323 Property, plant, and equipment 4,570 4,788 Investment property 2 2 Investments in equity-accounted investees 173 197 Other investments 85 8
Slide 38: Balance Sheet – Equity and Liabilities
Interim 2026 IFRS Consolidated Financial Statements Balance Sheet – Equity and Liabilities € millions 30.06.2026 31.12.2025 Subscribed capital 250 250 Capital reserves 9,676 9,677 Retained earnings –638 90 Other comprehensive income –571 –938 Equity attributable to the shareholders of the parent 8,7
Slide 39: Cash Flow (1/2)
Interim 2026 IFRS Consolidated Financial Statements Cash Flow (1/2) € millions H1 2026 H1 2025 Net income –593 –212 Income tax expense 25 117 Financial result 99 –48 EBIT –469 –144 Interest paid –26 –85 Interest received 21 34 Income tax paid –143 –176 Dividends received 1 47 Depreciation, amortizat
Slide 40: Cash Flow (2/2)
Interim 2026 IFRS Consolidated Financial Statements Cash Flow (2/2) € millions H1 2026 H1 2025 Disposal of property, plant and equipment, and intangible assets 13 16 Capital expenditure on property, plant and equipment, and software –193 –301 Capital expenditure on intangible assets from development
Slide 41: Financial calendar
Financial calendar 2026 November − Quarterly statement (November 5) Investor Relations @AUMOVIO SE H1 2026 Results 6 August 2026 41
Slide 42: Investor Relations contacts
Lutz Ackermann Niclas Neff Head of Investor Relations Senior Manager Investor Relations +49 69 7603-1890 +49 69 7603-8574 lutz.ackermann@aumovio.com niclas.neff@aumovio.com Dr. Sebastian Zier Manager Investor Relations +49 69 7603-2355 Sebastian.zier@aumovio.com Guerickestraße 7 | 60488 Frankfurt am
Slide 43: Glossary
Glossary 1 | Adj. Sales is calculated as sales adjusted for changes in the scope of consolidation. 2 | Adj. net R&D-to-sales-ratio calculated as adj. net R&D as percentage of adj. Sales. 3 I Adj. EBIT is defined as EBIT before amortization of intangible assets from purchase price allocation (PPA), c
Slide 44: Disclaimer
Disclaimer This presentation has been prepared by AUMOVIO SE (together with its consolidated subsidiaries, “AUMOVIO”) solely for information purposes. It has not been independently verified and will not be updated. It does not constitute an offer, invitation or recommendation to purchase or subscrib
Slide 45: AUMOVIO
4. AUMOVIO